FDA Panel Backs Moderna Vaccine, But Trial Unblinding A Key Concern

By Beth Wang / December 17, 2020 at 8:37 PM
FDA’s vaccine advisers on Thursday (Dec. 17) voted overwhelmingly in favor of authorizing Moderna’s COVID-19 vaccine for emergency use for people 18 and older, with 20 voting “yes” that the benefits outweigh the risks and one abstaining, but the advisers were mixed on Moderna’s plan to redesign and unblind its trial once an emergency use authorization is issued. Some members of FDA’s vaccine advisory panel said Moderna’s unblinding plan is a reasonable solution for a complicated situation, while others expressed...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.